Differences between a drug regimen employed in early phase 1 trials and the subsequent use of the agent in routine oncologic practice: a note of caution
- PMID: 17879372
- DOI: 10.1002/cncr.22967
Differences between a drug regimen employed in early phase 1 trials and the subsequent use of the agent in routine oncologic practice: a note of caution
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
